CFDE Data Portal | Search RPL3P6

	Label	Description
	RPL3P6 associations Collection (Entity type)	Associations for RPL3P6_associations
	RPL3P6 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	RPL3P6 Gene (Entity type)	ENSG00000213891 - ribosomal protein L3 pseudogene 6
	GSE228017 parthenolide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126463 pomalidomide MM1.S 6 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE221329 ERK BRAF inhibition thyroid gland 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Testis 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx

RPL3P6 associations

Associations for RPL3P6_associations

RPL3P6 associations.tsv

A file from IDG as part of the Harmonizome project

RPL3P6

ENSG00000213891 - ribosomal protein L3 pseudogene 6

GSE228017 parthenolide 0 v 1 human up

A Gene Set from LINCS

GSE113655 phenol 3 v 2 human dn

A Gene Set from LINCS

GSE113655 phenol 3 v 6 human dn

A Gene Set from LINCS

GSE126463 pomalidomide MM1.S 6 v 3 human dn

A Gene Set from LINCS

GSE221329 ERK BRAF inhibition thyroid gland 1 v 2 human dn

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 3 human up

A Gene Set from LINCS

GTEx Testis 20-29 vs 40-49 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.